oliceirdine
-
King of Prussia’s Trevena Begins Late-Stage Clinical Trials for New Pain Medicine
Trevena, a King of Prussia-based biopharmaceutical company, has started two late-stage clinical trials on its experimental pain medicine, oliceirdine, writes…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
